RAC 2.92% $1.94 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-127

  1. 2,658 Posts.
    lightbulb Created with Sketch. 2792
    some rhetorical questions…

    why would Bisantrene work after 8 lines of treatment?

    Would Sheba 2 results determine why it works I.e. Dominissini Data?

    How long until we get the results?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.